1. Herb-drug interactions of silybinin and cilofexor in beagle dogs based on pharmacokinetics by UPLC-MS/MS
   Xinyi Wei et al, 2024, Frontiers in Pharmacology CrossRef
2. Silibinin ameliorates deoxycholic acid-induced pyroptosis in steatotic HepG2 cells by inhibiting NLRP3 inflammasome activation
   Meiqing Mai et al, 2023, Biochemistry and Biophysics Reports CrossRef
3. Silibinin, a commonly used therapeutic agent for non‐alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19
   Yujie Bai et al, 2024, British Journal of Pharmacology CrossRef
4. Supplementation with optimized multivitamin premix relieves liver steatosis by inhibiting CD36 palmitoylation and regulating intestinal microorganisms in largemouth bass (Micropterus salmoides)
   Luohai Hua et al, 2024, Aquaculture Reports CrossRef
5. Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review
   Pervej Alom Barbhuiya et al, 2023, Phytochemistry Reviews CrossRef
6. In Vitro Influence of Specific Bacteroidales Strains on Gut and Liver Health Related to Metabolic Dysfunction-Associated Fatty Liver Disease
   Diego Garcia-Morena et al, 2024, Probiotics and Antimicrobial Proteins CrossRef
7. Targeting dysregulated lipid metabolism in the tumor microenvironment
   Do-Hee Kim et al, 2023, Archives of Pharmacal Research CrossRef
8. Diastereoisomer separation of silybin A and silybin B by semi‐preparative liquid chromatography using Box–Behnken design
   Hong Liu et al, 2023, SEPARATION SCIENCE PLUS CrossRef
9. Highly Accessible Computational Prediction and In Vivo/In Vitro Experimental Validation: Novel Synthetic Phenyl Ketone Derivatives as Promising Agents against NAFLD via Modulating Oxidoreductase Activity
   Yanan Qiao et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
10. Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action
    Vasudevan Sekar et al, 2024, Journal of Food Science and Technology CrossRef
11. Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD
    Han Zhang et al, 2021, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef
12. Silibinin protects GLUTag cells from PA-induced injury via suppressing endoplasmic reticulum stress
    Xinyi Shi et al, 2023, CyTA - Journal of Food CrossRef
13. An analysis of silybin meglumine tablets in the treatment of drug‐induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database
    Bo Zhang et al, 2023, British Journal of Clinical Pharmacology CrossRef